The use of optical sensors to understand cellular interactions with renal cells

Renal Failure

Volumn 21, Issue 3-4, 1999, Pages 349-357

  Newman, David J ^a   Thakkar, Hansa ^b   Lam Po Tang, Michael K ^a   Kwan, Jonathan T C ^a  

^a ST HELIER HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Human mesangial cells; LLCPK cells; Optical sensors

Indexed keywords

ALBUMIN; CARBOXYMETHYLDEXTRAN;

BINDING AFFINITY; BIOSENSOR; CELL CULTURE; CELL INTERACTION; CONFERENCE PAPER; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CELL; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; MESANGIUM CELL; OPTICAL INSTRUMENTATION; PRIORITY JOURNAL; PROTEIN INTERACTION; RECEPTOR BINDING;

EID: 0033058536     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229909085098     Document Type: Conference Paper

References (25)

1. Christensen EI, Bim H, Verroust P, Moestrup SK: Membrane receptors for endocytosis in the renal proximal tubule. Int Rev Cytol 180:237-284, 1998.
2. Simonnet H, Gauthier C, Vincent C, Revillard JP: The binding of beta-2 microglobulin to renal brush-border membrane: affinity measurement, inhibition by serum albumin. Biochim et Biophys Acta 940:247-254, 1988.
3. Christensen EI, Bim H, Verroust P, Moestrup SK: Megalin-mediated endocytosis in renal proximal tubule. Ren Fail 20:191-199, 1998.
4. Brunskill NJ, Nahorski S, Walls J: Characteristics of albumin binding to opposum kidney cells and identification of potential receptors. Pflugers Arch, 433:497-504, 1997.
5. Skolnik EY, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H: Human and rat mesangial cell receptors for glucose-modified proteins: Potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 174:931-939, 1991.
6. Edwards PR, Gill A, Pollard-Knight DV, Hoare M, Buckle PE, Lowe PA, Leatherbarrow RJ: Kinetics of protein-protein interactions at the surface of an optical biosensor. Anal Biochem 231:210-217, 1995.
7. Nieba L, K̀rebber A, Pluckthun A: Competition BIAcore for measuring true affinities: large differences from values determined from binding kinetics. Anal Biochem 234:155-165, 1996.
8. Morgan CL, Newman DJ, Lowe P, Price CP: Real-time analysis of the kinetics of cell surface assembly of class I MHC molecules. Biosen Bioelect 13:1099-1105, 1998.
9. Thakkar H, Newman DJ, Lowe PA, Price CP: The kinetics and specificity of protein uptake by proximal tubular cells using an optical sensor. Kidney Int 54:1197-1205, 1998.
10. Cohen MP: Diabetes and Protein Glycosylation: Measurement and Biologic Relevance. New York: Springer-Verlag, 1986.
11. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318(20):1315-1321, 1988.
12. Vlassara H, Striker LJ, Teichberg S, Fuh H, Li YM, Steffes M: Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Nat Acad Sci USA 91(24):11704-11708, 1994.
13. Papanastasiou P, Grass L, Rodela H, Patrikarea A, Oreopoulos D, Diamandis EP: Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int; 46:216-222, 1994.
14. Makino H, Shikata K, Hironaka K, et al.: UKrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. Kidney Int 4:517-526, 1995.
15. Nishino T, Horii Y, Shiiki H, et al.: Immunohistochemical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathy. Hum Pathol 26(3):308-313, 1995.
16. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ: Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Nat Acad Sci U.S.A 89:2873-2877, 1992.
17. Yazaki K: Effects of glycated protein on the expression of very late antigen 5 (VLA5), a fibronectin receptor, of cultured rat mesangial cells. Nippon Junzo Gakkai Shi 36(11):1251-1257, 1994.
18. Throckmorton DC, Brogden AP, Min B, Rasmussen H, Kashgarian M: PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int, 48(1):111-117, 1995.
19. Esposito C, Gerlach H, Brett J, Stern D, Vlassara H: Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med, 170(4):1387-1407, 1989.
20. Schmidt A, Vianna M, Gerlach M, et al.: Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267(21):14987-14997, 1992.
21. Yang Z, Makita Z, Horii Y, et al.: Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins. J Exp Med 174(3):515-524, 1991.
22. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H: Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Nat Acad Sci USA 87(22):9010-90141, 1990.
23. Neeper M, Schmidt A, Brett J, et al.: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267(21):14998-15004, 1992.
24. Abel M, Ritthaler U, Zhang Y, et al.: Expression of receptors for advanced glycosylated end-products in renal disease. Nephrol Dial Transpant 10:1662-1667, 1995.
25. Makita Z, Vlassara H, Cerami A, Bucala R: Immunochemical detection of advanced glycosylation end products in vivo. J.Biol Chem 267:5133-5138, 1992.